title: Subcutaneous abscess as a side-effect of cetuximab therapy.
authors.forename: Cristina
authors.initials: C
authors.lastname: Guerriero
authors.forename: Francesco
authors.initials: F
authors.lastname: Ricci
authors.forename: Andrea
authors.initials: A
authors.lastname: Paradisi
authors.forename: Barbara
authors.initials: B
authors.lastname: Fossati
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Valentini
authors.forename: Fabio
authors.initials: F
authors.lastname: Pacelli
authors.forename: Rodolfo
authors.initials: R
authors.lastname: Capizzi
mesh_terms: D000038:Abscess / Q000139:chemically induced*; D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002081:Buttocks; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D000068818:Cetuximab; D004815:Epidermal Growth Factor / Q000037:antagonists & inhibitors; D006801:Humans; D008297:Male; D014067:Tonsillar Neoplasms / Q000188:drug therapy
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D004815:Epidermal Growth Factor; D000068818:Cetuximab